GSK Investigational Site

Alken 3570

1 studies enrolling now · 2 studies all time

What they study most

Chickenpox, Respiratory Syncytial Virus Infections

Studies at this site

• A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age — Recruiting now
• Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above — Completed